LoginRegister
    Tech Giant Google collaborates with Doctors to help recognise diseasesTech Giant Google collaborates with Doctors to help recognise diseases
    Granules India arm wins USFDA approval for stimulant drug Amphetamine Sulfate tabletsGranules India arm wins USFDA approval for stimulant drug Amphetamine Sulfate tablets
    Fortis Healthcare reports profit of Rs 78 crore for June quarterFortis Healthcare reports profit of Rs 78 crore for June quarter
    Daiichi Sankyo CEO capped USD 37 billion recovery with AstraZeneca deal: BloombergDaiichi Sankyo CEO capped USD 37 billion recovery with AstraZeneca deal: Bloomberg
    Novo Nordisk buys drug factory in North Carolina for assistance in manufacturing, packaging new diabetes drugNovo Nordisk buys drug factory in North Carolina for assistance in manufacturing, packaging new...
    Phase III PARAGON-HF Trial: Novartis announces results of sacubitril-valsartan trial in heart failure patients with preserved ejection fractionPhase III PARAGON-HF Trial: Novartis announces results of sacubitril-valsartan trial in heart...
    HCL Technologies and Oracle Health Sciences Collaborate to Accelerate MHealth in Clinical TrialsHCL Technologies and Oracle Health Sciences Collaborate to Accelerate MHealth in Clinical Trials
    Natco Pharma gets EIR from USFDA for Kothur facilityNatco Pharma gets EIR from USFDA for Kothur facility
    Ananth Narayanan joins Medlife as co-founder and CEOAnanth Narayanan joins Medlife as co-founder and CEO
    Nestle, 5 Top Hospitals Including Gangaram, Manipal under scanner over clinical trials on 75 premature infants: Govt asks ICMR to probeNestle, 5 Top Hospitals Including Gangaram, Manipal under scanner over clinical trials on 75...
    Zydus Cadila completes phase III trial of Diabetes drug Lipaglyn in IndiaZydus Cadila completes phase III trial of Diabetes drug Lipaglyn in India
    Lupin gets EIR from USFDA for Oral Dosage facility in AurangabadLupin gets EIR from USFDA for Oral Dosage facility in Aurangabad
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X